1. Introduction arsenal for the treatment of osteoporosis

   • Takuo Fujita

   OriginalPaper Pages: S5 - S5

2. DXA assessment of the synergistic effects of long-term ipriflavone treatment and activities of daily living on bone mass in osteoporosis

   • Sumio Goto
   • Makoto Kurihara
   • Hideshige Moriya

   Section I: Orthopaedics Pages: S8 - S14

3. The effect of ipriflavone on bone mass of osteoporotic women: Single-agent and multi-agent combination ADFR therapy

   • Hideaki Kishimoto
   • Kichizo Yamamoto

   Section I: Orthopaedics Pages: S15 - S19

4. Effect of ipriflavone on bone mineral content in osteoporotic patients

   • Toshitsugu Sugimoto
   • Masaaki Fukase
   • Takuo Fujita

   Section II: Internal Medicine Pages: S22 - S25

5. Effect of ipriflavone on bone mineral density of lumbar spine of aged women

   • Takami Miki
   • Hideyuki Aratani
   • Hirotoshi Morii

   Section II: Internal Medicine Pages: S26 - S29

6. Effects of 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one (ipriflavone) on serum levels of calcitonin and parathyroid hormone in patients with adult-onset diabetes

   • Kiyoshi Hashizume
   • Kazuo Ichikawa
   • Xiao-Yun Ma

   Section II: Internal Medicine Pages: S30 - S37

7. The influence of ipriflavone on bone metabolism and reduction of bone mineral density decrease by ipriflavone following menopause or bilateral oophorectomy

   • Hiroaki Ohta
   • Shigeyuki Komukai
   • Shiro Nozawa

   Section III: Obstetrics And Gynaecology Pages: S40 - S45

8. The effect of ipriflavone on osteopenia in ovariectomized women

   • Itsuo Gorai
   • Osamu Chaki
   • Hiroshi Minaguchi

   Section III: Obstetrics And Gynaecology Pages: S46 - S50

9. Recent findings in the diagnosis and prevention of osteoporosis

   • Tetsuo Inoue

   Special Lecture: Reviews Pages: S52 - S58

10. Preventative treatment of involutional osteoporosis

    • Hajime Orimo

    Special Lecture: Reviews Pages: S59 - S64